UMIN000049203Not yet recruiting
Investigation of the efficacy of Imeglimin on glycemic control and the underlying mechanisms
Evaluation of effect on the postprandial glucose elevation and glycemic variability of Imeglimin
Toho universityUniversity Hospital Medical Information Networkdrug
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- Type 2 diabetes
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Toho university
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Oct 13, 2022
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000049203
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000049203 through Pure Global AI's free database. This phase not specified trial is sponsored by Toho university and is currently Not yet recruiting. The study focuses on Type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.